PMID- 25023988 OWN - NLM STAT- MEDLINE DCOM- 20150511 LR - 20211021 IS - 1460-2180 (Electronic) IS - 0143-3334 (Print) IS - 0143-3334 (Linking) VI - 35 IP - 10 DP - 2014 Oct TI - A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis. PG - 2291-9 LID - 10.1093/carcin/bgu147 [doi] AB - We recently demonstrated that both murine and human carcinomas grow significantly slower in mice on low carbohydrate (CHO), high protein diets than on isocaloric Western diets and that a further reduction in tumor growth rates occur when the low CHO diets are combined with the cyclooxygenase-2 inhibitor, celecoxib. Following upon these studies, we asked herein what effect low CHO, high protein diets, with or without celecoxib, might have on tumor metastasis. In the highly metastatic 4T1 mouse mammary tumor model, a 15% CHO, high protein diet supplemented with celecoxib (1 g/kg chow) markedly reduced lung metastases. Moreover, in longer-term studies using male Transgenic Adenocarcinoma of the Mouse Prostate mice, which are predisposed to metastatic prostate cancer, the 15% CHO diet, with and without celecoxib (0.3 g/kg chow), gave the lowest incidence of metastases, but a more moderate 25% CHO diet containing celecoxib led to the best survival. Metabolic studies with 4T1 tumors suggested that the low CHO, high protein diets may be forcing tumors to become dependent on amino acid catabolism for survival/growth. Taken together, our results suggest that a combination of a low CHO, high protein diet with celecoxib substantially reduces metastasis. CI - (c) The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. FAU - Ho, Victor W AU - Ho VW AD - The Terry Fox Laboratory and. FAU - Hamilton, Melisa J AU - Hamilton MJ AD - The Terry Fox Laboratory and The Integrative Oncology Department, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. FAU - Dang, Ngoc-Ha Thi AU - Dang NH AD - The Department of Biological Sciences and the Metabolomics Centre, University of Calgary, Calgary, Alberta T2N 1N4, Canada and. FAU - Hsu, Brian E AU - Hsu BE AD - The Terry Fox Laboratory and. FAU - Adomat, Hans H AU - Adomat HH AD - The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia V6H 3Z6, Canada. FAU - Guns, Emma S AU - Guns ES AD - The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia V6H 3Z6, Canada. FAU - Weljie, Aalim AU - Weljie A AD - The Department of Biological Sciences and the Metabolomics Centre, University of Calgary, Calgary, Alberta T2N 1N4, Canada and. FAU - Samudio, Ismael AU - Samudio I AD - The Terry Fox Laboratory and. FAU - Bennewith, Kevin L AU - Bennewith KL AD - The Department of Biological Sciences and the Metabolomics Centre, University of Calgary, Calgary, Alberta T2N 1N4, Canada and. FAU - Krystal, Gerald AU - Krystal G AD - The Terry Fox Laboratory and gkrystal@bccrc.ca. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140714 PL - England TA - Carcinogenesis JT - Carcinogenesis JID - 8008055 RN - 0 (Dietary Proteins) RN - 0 (Pyrazoles) RN - 0 (Sulfonamides) RN - JCX84Q7J1L (Celecoxib) SB - IM MH - Animals MH - Celecoxib MH - Diet Therapy/methods MH - *Diet, Carbohydrate-Restricted MH - Dietary Proteins/*pharmacology MH - Disease Models, Animal MH - Lung Neoplasms/diet therapy/drug therapy/secondary MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Neoplasm Metastasis/*drug therapy/therapy MH - Prostatic Neoplasms/diet therapy/drug therapy/metabolism/pathology MH - Pyrazoles/*pharmacology MH - Sulfonamides/*pharmacology PMC - PMC4178469 EDAT- 2014/07/16 06:00 MHDA- 2015/05/12 06:00 PMCR- 2015/10/01 CRDT- 2014/07/16 06:00 PHST- 2014/07/16 06:00 [entrez] PHST- 2014/07/16 06:00 [pubmed] PHST- 2015/05/12 06:00 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - bgu147 [pii] AID - 10.1093/carcin/bgu147 [doi] PST - ppublish SO - Carcinogenesis. 2014 Oct;35(10):2291-9. doi: 10.1093/carcin/bgu147. Epub 2014 Jul 14.